Every year, mil­lions of can­cer patients could be saved
from pre­ma­ture death and suf­fer­ing if they had timely
access to early detec­tion and treatment.

World Health Organization

Onco­Lab Diag­nos­tics con­tributes sub­stan­tially to enhanc­ing sur­vival time and qual­ity of life of can­cer patients and reduc­ing can­cer mor­tal­ity by devel­op­ing, man­u­fac­tur­ing and mar­ket­ing highly inno­v­a­tive and utmost pre­cise can­cer tests.

To achieve our goals we engage in research and devel­op­ment activ­i­ties in close coop­er­a­tion with renowned world­wide acad­e­mia and indus­try part­ners. Onco­lab Diag­nos­tics is ded­i­cated to research and devel­op­ment to find new means and tech­nolo­gies to diag­nose can­cer at much ear­lier stages.